DR. LAL PATHLABS LIMITED Dr. Lal PathLabs Limited Share Price
Equities
LALPATHLAB
INE600L01024
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,351 INR | -0.89% |
|
+4.54% | -8.78% |
| 26/04 | Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer, Effective May 9, 2024 | CI |
| 18/03 | Dr Lal Pathlabs Names CEO | MT |
| Sales 2024 * | 22.35B 268M | Sales 2025 * | 24.91B 299M | Capitalization | 197B 2.36B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.56B 42.73M | Net income 2025 * | 4.15B 49.77M | EV / Sales 2024 * | 8.47 x |
| Net cash position 2024 * | 7.72B 92.61M | Net cash position 2025 * | 10.99B 132M | EV / Sales 2025 * | 7.47 x |
| P/E ratio 2024 * |
55.5
x | P/E ratio 2025 * |
47.7
x | Employees | 4,048 |
| Yield 2024 * |
0.72% | Yield 2025 * |
0.77% | Free-Float | 43.28% |
More Fundamentals
* Assessed data
More news
Latest transcript on Dr. Lal PathLabs Limited
More recommendations
| 1 day | -0.89% | ||
| 1 week | +4.54% | ||
| Current month | +3.92% | ||
| 1 month | +2.76% | ||
| 3 months | -5.04% | ||
| 6 months | -0.51% | ||
| Current year | -8.78% |
1 week
2 249.40
2 430.85
1 month
2 165.802 430.85
Current year
1 943.702 662.00
1 year
1 888.102 767.10
3 years
1 762.054 245.50
5 years
955.004 245.50
10 years
696.504 245.50
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/16/01 | |
Ved Prakash Goel
DFI | Director of Finance/CFO | - | 01/06/01 |
Arvind Lal
CHM | Chairman | 74 | 14/95/14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 27/23/27 | |
| Director/Board Member | 77 | 21/15/21 | |
Arvind Lal
CHM | Chairman | 74 | 14/95/14 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.10% | 6 M€ | +6.07% | - | |
| 0.01% | 4 M€ | -4.41% | - | |
| 0.01% | 117 M€ | -0.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/24/02 | 2,351 | -0.89% | 69 801 |
| 30/24/30 | 2,372 | +1.09% | 197,584 |
| 29/24/29 | 2,347 | -1.73% | 425,813 |
| 26/24/26 | 2,388 | +2.48% | 266,846 |
| 25/24/25 | 2,331 | +0.08% | 116,745 |
Delayed Quote NSE India S.E., May 02, 2024 at 03:00 pm IST
More quotes
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Companyâs subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
Calendar
17/05/2024
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
2,372
INR
Average target price
2,449
INR
Spread / Average Target
+3.24%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.78% | 2.36B | |
| -19.14% | 8.22B | |
| +45.10% | 3.73B | |
| -7.18% | 2.46B | |
| -38.71% | 2.46B | |
| -13.72% | 1.78B | |
| -19.73% | 1.52B | |
| -40.78% | 1.21B | |
| +8.32% | 1.12B | |
| -12.27% | 1.09B |
- Stock Market
- Equities
- LALPATHLAB Stock
